Treatments are available for dry AMD patients who also have geographic atrophy, but until the FDA's recent authorization of ...

Dubai, UAE: The Emirates Drug Establishment (EDE) has announced the approval of Itvisma™ (onasemnogene abeparvovec), a gene therapy that uses an adeno-associated viral vector to treat spinal muscular ...

The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that uses an adeno-associated viral vector to treat spinal muscular atrophy (SMA) ...

The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that uses an adeno-associated viral vector to treat spinal muscular atrophy (SMA) ...

X-linked retinoschisis gene replacement therapy, aiming to improve retinal architecture and visual function in young male ...

The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that ...

A push to reshore some drug production and progress in advanced manufacturing technologies have been prominent trends this year, industry leaders say.

The global physiotherapy equipment market is projected to expand at a CAGR of approximately 7% through 2026. Market growth is being driven by the increasing demand for rehabilitation centers, a ...

Shionogi to purchase the rights and assets of the global RADICAVA business establishing a strong commercial platform in rare disease to support future launchesAs part of the transaction, a new ...

Learn more about whether PTC Therapeutics, Inc. or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The conundrum is stark and uncomfortable: skilled Ghanaian professionals who deliver exemplary work in London, Toronto or New York return home to become unreliable employees. The same artisan who ...